Skip to main content
Figure 1 | Cardiovascular Diabetology

Figure 1

From: Achievement of recommended glucose and blood pressure targets in patients with type 2 diabetes and hypertension in clinical practice – study rationale and protocol of DIALOGUE

Figure 1

Sample size and segmentation into strata of different antidiabetic-treatments. Legend: Patients are eligible for inclusion if treated with oral mono or dual combination therapy and are distributed into the following groups: Incretin-based treatments include DPP-4 inhibitors and GLP-1 analogues. Non-incretin-based therapies include metformin, sulfonylureas, acarbose, insulin, alpha-glucosidase inhibitors, and SGLT2-inhibitors.

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840